nodes	percent_of_prediction	percent_of_DWPC	metapath
Tenofovir—ABCC10—Daunorubicin—hematologic cancer	0.0441	0.128	CbGbCtD
Tenofovir—ABCC4—Tioguanine—hematologic cancer	0.0395	0.115	CbGbCtD
Tenofovir—ABCC10—Cytarabine—hematologic cancer	0.0389	0.113	CbGbCtD
Tenofovir—Adenosine triphosphate—Nelarabine—hematologic cancer	0.0287	0.0637	CrCrCtD
Tenofovir—S-Adenosylmethionine—Clofarabine—hematologic cancer	0.0264	0.0585	CrCrCtD
Tenofovir—S-Adenosylmethionine—Nelarabine—hematologic cancer	0.0248	0.055	CrCrCtD
Tenofovir—ABCC10—Gemcitabine—hematologic cancer	0.0237	0.0687	CbGbCtD
Tenofovir—Adenosine—Pentostatin—hematologic cancer	0.0235	0.0522	CrCrCtD
Tenofovir—Vidarabine—Pentostatin—hematologic cancer	0.0235	0.0522	CrCrCtD
Tenofovir—Adenosine monophosphate—Clofarabine—hematologic cancer	0.0233	0.0517	CrCrCtD
Tenofovir—Adenosine triphosphate—Fludarabine—hematologic cancer	0.0224	0.0497	CrCrCtD
Tenofovir—Adenosine monophosphate—Nelarabine—hematologic cancer	0.0219	0.0486	CrCrCtD
Tenofovir—Vidarabine—Clofarabine—hematologic cancer	0.021	0.0465	CrCrCtD
Tenofovir—Adenosine—Clofarabine—hematologic cancer	0.021	0.0465	CrCrCtD
Tenofovir—Vidarabine—Nelarabine—hematologic cancer	0.0197	0.0437	CrCrCtD
Tenofovir—Adenosine—Nelarabine—hematologic cancer	0.0197	0.0437	CrCrCtD
Tenofovir—S-Adenosylmethionine—Fludarabine—hematologic cancer	0.0194	0.043	CrCrCtD
Tenofovir—ABCC10—Vincristine—hematologic cancer	0.0184	0.0535	CbGbCtD
Tenofovir—S-Adenosylmethionine—Cytarabine—hematologic cancer	0.0183	0.0406	CrCrCtD
Tenofovir—Adenosine monophosphate—Fludarabine—hematologic cancer	0.0171	0.038	CrCrCtD
Tenofovir—ABCC10—Etoposide—hematologic cancer	0.0169	0.049	CbGbCtD
Tenofovir—ABCC4—Mercaptopurine—hematologic cancer	0.0164	0.0476	CbGbCtD
Tenofovir—Adenosine monophosphate—Cytarabine—hematologic cancer	0.0162	0.0359	CrCrCtD
Tenofovir—Adenosine monophosphate—Cladribine—hematologic cancer	0.0158	0.035	CrCrCtD
Tenofovir—Adenosine—Fludarabine—hematologic cancer	0.0154	0.0341	CrCrCtD
Tenofovir—Vidarabine—Fludarabine—hematologic cancer	0.0154	0.0341	CrCrCtD
Tenofovir—Adenosine—Cytarabine—hematologic cancer	0.0145	0.0322	CrCrCtD
Tenofovir—Vidarabine—Cytarabine—hematologic cancer	0.0145	0.0322	CrCrCtD
Tenofovir—Vidarabine—Cladribine—hematologic cancer	0.0142	0.0314	CrCrCtD
Tenofovir—Adenosine—Cladribine—hematologic cancer	0.0142	0.0314	CrCrCtD
Tenofovir—ABCC2—Daunorubicin—hematologic cancer	0.0126	0.0366	CbGbCtD
Tenofovir—CYP1A2—Anagrelide—hematologic cancer	0.0116	0.0336	CbGbCtD
Tenofovir—ABCC10—Doxorubicin—hematologic cancer	0.0115	0.0334	CbGbCtD
Tenofovir—ABCC10—Methotrexate—hematologic cancer	0.0112	0.0324	CbGbCtD
Tenofovir—SLC22A8—Mercaptopurine—hematologic cancer	0.0102	0.0298	CbGbCtD
Tenofovir—CYP1A2—Carmustine—hematologic cancer	0.00607	0.0176	CbGbCtD
Tenofovir—ABCC2—Irinotecan—hematologic cancer	0.00602	0.0175	CbGbCtD
Tenofovir—ABCC4—Methotrexate—hematologic cancer	0.00536	0.0156	CbGbCtD
Tenofovir—ABCC2—Vinblastine—hematologic cancer	0.00536	0.0156	CbGbCtD
Tenofovir—ABCC2—Vincristine—hematologic cancer	0.00527	0.0153	CbGbCtD
Tenofovir—CYP1A2—Methoxsalen—hematologic cancer	0.00516	0.015	CbGbCtD
Tenofovir—ABCC2—Cisplatin—hematologic cancer	0.00491	0.0143	CbGbCtD
Tenofovir—CYP1A2—Bortezomib—hematologic cancer	0.00491	0.0143	CbGbCtD
Tenofovir—ABCC2—Etoposide—hematologic cancer	0.00483	0.014	CbGbCtD
Tenofovir—CYP1A2—Daunorubicin—hematologic cancer	0.00469	0.0136	CbGbCtD
Tenofovir—CYP1A2—Alitretinoin—hematologic cancer	0.0046	0.0134	CbGbCtD
Tenofovir—CYP1A2—Thalidomide—hematologic cancer	0.00428	0.0124	CbGbCtD
Tenofovir—ABCC2—Dexamethasone—hematologic cancer	0.00397	0.0115	CbGbCtD
Tenofovir—CYP1A2—Dacarbazine—hematologic cancer	0.00368	0.0107	CbGbCtD
Tenofovir—CYP1A2—Imatinib—hematologic cancer	0.0036	0.0104	CbGbCtD
Tenofovir—SLC22A8—Methotrexate—hematologic cancer	0.00335	0.00973	CbGbCtD
Tenofovir—ABCC2—Doxorubicin—hematologic cancer	0.00329	0.00956	CbGbCtD
Tenofovir—ABCC2—Methotrexate—hematologic cancer	0.00319	0.00926	CbGbCtD
Tenofovir—NME1-NME2—hematopoietic system—hematologic cancer	0.00291	0.0868	CbGeAlD
Tenofovir—CYP1A2—Dasatinib—hematologic cancer	0.00289	0.00839	CbGbCtD
Tenofovir—SLC22A6—Methotrexate—hematologic cancer	0.00233	0.00678	CbGbCtD
Tenofovir—CYP1A2—Etoposide—hematologic cancer	0.0018	0.00522	CbGbCtD
Tenofovir—NME1—hematopoietic system—hematologic cancer	0.00169	0.0505	CbGeAlD
Tenofovir—NME2—hematopoietic system—hematologic cancer	0.0016	0.0476	CbGeAlD
Tenofovir—AK2—blood—hematologic cancer	0.00146	0.0436	CbGeAlD
Tenofovir—AK2—bone marrow—hematologic cancer	0.00141	0.0422	CbGeAlD
Tenofovir—AK2—lung—hematologic cancer	0.00128	0.0382	CbGeAlD
Tenofovir—AK4—gonad—hematologic cancer	0.00124	0.037	CbGeAlD
Tenofovir—AK2—testis—hematologic cancer	0.00121	0.036	CbGeAlD
Tenofovir—NME1-NME2—lymph node—hematologic cancer	0.00116	0.0345	CbGeAlD
Tenofovir—NME1—bone marrow—hematologic cancer	0.00109	0.0324	CbGeAlD
Tenofovir—NME2—blood—hematologic cancer	0.00106	0.0315	CbGeAlD
Tenofovir—NME1—lung—hematologic cancer	0.000984	0.0293	CbGeAlD
Tenofovir—AK4—lung—hematologic cancer	0.000948	0.0283	CbGeAlD
Tenofovir—NME1—testis—hematologic cancer	0.000928	0.0277	CbGeAlD
Tenofovir—NME2—lung—hematologic cancer	0.000926	0.0276	CbGeAlD
Tenofovir—AK4—testis—hematologic cancer	0.000894	0.0267	CbGeAlD
Tenofovir—AK2—lymph node—hematologic cancer	0.000876	0.0261	CbGeAlD
Tenofovir—NME2—testis—hematologic cancer	0.000874	0.0261	CbGeAlD
Tenofovir—NME1—Ponatinib—Nilotinib—hematologic cancer	0.000831	0.504	CbGdCrCtD
Tenofovir—ABCC10—hematopoietic system—hematologic cancer	0.000774	0.0231	CbGeAlD
Tenofovir—NME1—lymph node—hematologic cancer	0.000673	0.0201	CbGeAlD
Tenofovir—AK4—lymph node—hematologic cancer	0.000648	0.0193	CbGeAlD
Tenofovir—ABCC4—hematopoietic system—hematologic cancer	0.000642	0.0191	CbGeAlD
Tenofovir—SLC22A8—hematopoietic system—hematologic cancer	0.000637	0.019	CbGeAlD
Tenofovir—NME2—lymph node—hematologic cancer	0.000634	0.0189	CbGeAlD
Tenofovir—NME1—Ponatinib—Imatinib—hematologic cancer	0.00063	0.382	CbGdCrCtD
Tenofovir—ABCC10—gonad—hematologic cancer	0.000589	0.0176	CbGeAlD
Tenofovir—Adenosine triphosphate—ASNS—hematologic cancer	0.000533	0.221	CrCbGaD
Tenofovir—ABCC10—blood—hematologic cancer	0.000513	0.0153	CbGeAlD
Tenofovir—ABCC10—bone marrow—hematologic cancer	0.000496	0.0148	CbGeAlD
Tenofovir—Adenosine monophosphate—CREB1—hematologic cancer	0.000466	0.193	CrCbGaD
Tenofovir—ABCC10—lung—hematologic cancer	0.00045	0.0134	CbGeAlD
Tenofovir—CYP1A2—hematopoietic system—hematologic cancer	0.000436	0.013	CbGeAlD
Tenofovir—ABCC4—blood—hematologic cancer	0.000426	0.0127	CbGeAlD
Tenofovir—ABCC10—testis—hematologic cancer	0.000424	0.0126	CbGeAlD
Tenofovir—SLC22A8—blood—hematologic cancer	0.000422	0.0126	CbGeAlD
Tenofovir—ABCC2—blood—hematologic cancer	0.000412	0.0123	CbGeAlD
Tenofovir—ABCC4—bone marrow—hematologic cancer	0.000412	0.0123	CbGeAlD
Tenofovir—Adenosine triphosphate—ABL2—hematologic cancer	0.000404	0.168	CrCbGaD
Tenofovir—ABCC4—lung—hematologic cancer	0.000373	0.0111	CbGeAlD
Tenofovir—ABCC4—testis—hematologic cancer	0.000352	0.0105	CbGeAlD
Tenofovir—ABCC2—testis—hematologic cancer	0.000341	0.0102	CbGeAlD
Tenofovir—ABCC10—lymph node—hematologic cancer	0.000308	0.00917	CbGeAlD
Tenofovir—CYP1A2—blood—hematologic cancer	0.000289	0.00862	CbGeAlD
Tenofovir—ABCC4—lymph node—hematologic cancer	0.000255	0.00761	CbGeAlD
Tenofovir—CYP1A2—lung—hematologic cancer	0.000253	0.00756	CbGeAlD
Tenofovir—ABCC2—lymph node—hematologic cancer	0.000247	0.00736	CbGeAlD
Tenofovir—Adenosine triphosphate—ALK—hematologic cancer	0.000245	0.102	CrCbGaD
Tenofovir—Adenosine triphosphate—AKT1—hematologic cancer	0.000191	0.0793	CrCbGaD
Tenofovir—Adenosine monophosphate—SRC—hematologic cancer	0.000188	0.0782	CrCbGaD
Tenofovir—Adenosine triphosphate—ABL1—hematologic cancer	0.00018	0.0749	CrCbGaD
Tenofovir—Adenosine monophosphate—PDE4B—hematologic cancer	0.000168	0.0699	CrCbGaD
Tenofovir—NME1—Fluticasone Propionate—Dexamethasone—hematologic cancer	6.36e-05	0.0386	CbGdCrCtD
Tenofovir—NME1—Fluticasone Propionate—Betamethasone—hematologic cancer	6.36e-05	0.0386	CbGdCrCtD
Tenofovir—NME1—Fluticasone Propionate—Triamcinolone—hematologic cancer	6.22e-05	0.0377	CbGdCrCtD
Tenofovir—Adenosine triphosphate—ABCB1—hematologic cancer	3.33e-05	0.0139	CrCbGaD
Tenofovir—Dyspepsia—Triamcinolone—hematologic cancer	2.33e-05	0.000203	CcSEcCtD
Tenofovir—Rash—Ifosfamide—hematologic cancer	2.33e-05	0.000203	CcSEcCtD
Tenofovir—Dermatitis—Ifosfamide—hematologic cancer	2.33e-05	0.000202	CcSEcCtD
Tenofovir—Neuropathy peripheral—Doxorubicin—hematologic cancer	2.33e-05	0.000202	CcSEcCtD
Tenofovir—Hyperhidrosis—Dexamethasone—hematologic cancer	2.32e-05	0.000202	CcSEcCtD
Tenofovir—Hyperhidrosis—Betamethasone—hematologic cancer	2.32e-05	0.000202	CcSEcCtD
Tenofovir—Dizziness—Irinotecan—hematologic cancer	2.32e-05	0.000202	CcSEcCtD
Tenofovir—Abdominal pain—Etoposide—hematologic cancer	2.31e-05	0.000201	CcSEcCtD
Tenofovir—Body temperature increased—Etoposide—hematologic cancer	2.31e-05	0.000201	CcSEcCtD
Tenofovir—Hepatitis—Epirubicin—hematologic cancer	2.3e-05	0.0002	CcSEcCtD
Tenofovir—Vomiting—Vincristine—hematologic cancer	2.29e-05	0.000199	CcSEcCtD
Tenofovir—Anorexia—Betamethasone—hematologic cancer	2.29e-05	0.000199	CcSEcCtD
Tenofovir—Anorexia—Dexamethasone—hematologic cancer	2.29e-05	0.000199	CcSEcCtD
Tenofovir—Asthenia—Cisplatin—hematologic cancer	2.28e-05	0.000199	CcSEcCtD
Tenofovir—Fatigue—Triamcinolone—hematologic cancer	2.28e-05	0.000198	CcSEcCtD
Tenofovir—Sweating—Doxorubicin—hematologic cancer	2.27e-05	0.000198	CcSEcCtD
Tenofovir—Urinary tract disorder—Epirubicin—hematologic cancer	2.27e-05	0.000198	CcSEcCtD
Tenofovir—Rash—Vincristine—hematologic cancer	2.27e-05	0.000198	CcSEcCtD
Tenofovir—Dermatitis—Vincristine—hematologic cancer	2.27e-05	0.000197	CcSEcCtD
Tenofovir—Pain—Triamcinolone—hematologic cancer	2.26e-05	0.000197	CcSEcCtD
Tenofovir—Haematuria—Doxorubicin—hematologic cancer	2.26e-05	0.000197	CcSEcCtD
Tenofovir—Connective tissue disorder—Epirubicin—hematologic cancer	2.26e-05	0.000197	CcSEcCtD
Tenofovir—Urethral disorder—Epirubicin—hematologic cancer	2.26e-05	0.000196	CcSEcCtD
Tenofovir—Headache—Vincristine—hematologic cancer	2.26e-05	0.000196	CcSEcCtD
Tenofovir—Hepatobiliary disease—Doxorubicin—hematologic cancer	2.24e-05	0.000195	CcSEcCtD
Tenofovir—Nausea—Carmustine—hematologic cancer	2.24e-05	0.000195	CcSEcCtD
Tenofovir—Vomiting—Irinotecan—hematologic cancer	2.23e-05	0.000194	CcSEcCtD
Tenofovir—Vomiting—Mitoxantrone—hematologic cancer	2.23e-05	0.000194	CcSEcCtD
Tenofovir—Sinusitis—Doxorubicin—hematologic cancer	2.23e-05	0.000194	CcSEcCtD
Tenofovir—Immune system disorder—Methotrexate—hematologic cancer	2.22e-05	0.000193	CcSEcCtD
Tenofovir—Nausea—Alitretinoin—hematologic cancer	2.22e-05	0.000193	CcSEcCtD
Tenofovir—Mediastinal disorder—Methotrexate—hematologic cancer	2.22e-05	0.000193	CcSEcCtD
Tenofovir—Rash—Mitoxantrone—hematologic cancer	2.21e-05	0.000192	CcSEcCtD
Tenofovir—Rash—Irinotecan—hematologic cancer	2.21e-05	0.000192	CcSEcCtD
Tenofovir—Dermatitis—Mitoxantrone—hematologic cancer	2.21e-05	0.000192	CcSEcCtD
Tenofovir—Dermatitis—Irinotecan—hematologic cancer	2.21e-05	0.000192	CcSEcCtD
Tenofovir—Headache—Mitoxantrone—hematologic cancer	2.2e-05	0.000191	CcSEcCtD
Tenofovir—Headache—Irinotecan—hematologic cancer	2.2e-05	0.000191	CcSEcCtD
Tenofovir—Nausea—Ifosfamide—hematologic cancer	2.19e-05	0.000191	CcSEcCtD
Tenofovir—Musculoskeletal discomfort—Betamethasone—hematologic cancer	2.19e-05	0.00019	CcSEcCtD
Tenofovir—Musculoskeletal discomfort—Dexamethasone—hematologic cancer	2.19e-05	0.00019	CcSEcCtD
Tenofovir—Arthralgia—Prednisone—hematologic cancer	2.18e-05	0.00019	CcSEcCtD
Tenofovir—Myalgia—Prednisone—hematologic cancer	2.18e-05	0.00019	CcSEcCtD
Tenofovir—Diarrhoea—Cisplatin—hematologic cancer	2.18e-05	0.00019	CcSEcCtD
Tenofovir—Anxiety—Prednisone—hematologic cancer	2.17e-05	0.000189	CcSEcCtD
Tenofovir—Vomiting—Gemcitabine—hematologic cancer	2.17e-05	0.000189	CcSEcCtD
Tenofovir—Insomnia—Dexamethasone—hematologic cancer	2.17e-05	0.000189	CcSEcCtD
Tenofovir—Insomnia—Betamethasone—hematologic cancer	2.17e-05	0.000189	CcSEcCtD
Tenofovir—Unspecified disorder of skin and subcutaneous tissue—Prednisone—hematologic cancer	2.17e-05	0.000188	CcSEcCtD
Tenofovir—Mental disorder—Methotrexate—hematologic cancer	2.15e-05	0.000187	CcSEcCtD
Tenofovir—Rash—Gemcitabine—hematologic cancer	2.15e-05	0.000187	CcSEcCtD
Tenofovir—Dermatitis—Gemcitabine—hematologic cancer	2.15e-05	0.000187	CcSEcCtD
Tenofovir—Hypersensitivity—Etoposide—hematologic cancer	2.15e-05	0.000187	CcSEcCtD
Tenofovir—Malnutrition—Methotrexate—hematologic cancer	2.14e-05	0.000186	CcSEcCtD
Tenofovir—Headache—Gemcitabine—hematologic cancer	2.14e-05	0.000186	CcSEcCtD
Tenofovir—Nausea—Vincristine—hematologic cancer	2.14e-05	0.000186	CcSEcCtD
Tenofovir—Hepatitis—Doxorubicin—hematologic cancer	2.13e-05	0.000185	CcSEcCtD
Tenofovir—Hypersensitivity—Prednisolone—hematologic cancer	2.12e-05	0.000184	CcSEcCtD
Tenofovir—Dyspepsia—Dexamethasone—hematologic cancer	2.11e-05	0.000184	CcSEcCtD
Tenofovir—Dyspepsia—Betamethasone—hematologic cancer	2.11e-05	0.000184	CcSEcCtD
Tenofovir—Urinary tract disorder—Doxorubicin—hematologic cancer	2.1e-05	0.000183	CcSEcCtD
Tenofovir—Asthenia—Etoposide—hematologic cancer	2.09e-05	0.000182	CcSEcCtD
Tenofovir—Connective tissue disorder—Doxorubicin—hematologic cancer	2.09e-05	0.000182	CcSEcCtD
Tenofovir—Body temperature increased—Triamcinolone—hematologic cancer	2.09e-05	0.000182	CcSEcCtD
Tenofovir—Urethral disorder—Doxorubicin—hematologic cancer	2.09e-05	0.000182	CcSEcCtD
Tenofovir—Decreased appetite—Dexamethasone—hematologic cancer	2.09e-05	0.000182	CcSEcCtD
Tenofovir—Decreased appetite—Betamethasone—hematologic cancer	2.09e-05	0.000182	CcSEcCtD
Tenofovir—Nausea—Mitoxantrone—hematologic cancer	2.08e-05	0.000181	CcSEcCtD
Tenofovir—Nausea—Irinotecan—hematologic cancer	2.08e-05	0.000181	CcSEcCtD
Tenofovir—Immune system disorder—Epirubicin—hematologic cancer	2.08e-05	0.000181	CcSEcCtD
Tenofovir—Mediastinal disorder—Epirubicin—hematologic cancer	2.07e-05	0.00018	CcSEcCtD
Tenofovir—Gastrointestinal disorder—Dexamethasone—hematologic cancer	2.07e-05	0.00018	CcSEcCtD
Tenofovir—Gastrointestinal disorder—Betamethasone—hematologic cancer	2.07e-05	0.00018	CcSEcCtD
Tenofovir—Back pain—Methotrexate—hematologic cancer	2.07e-05	0.00018	CcSEcCtD
Tenofovir—Fatigue—Betamethasone—hematologic cancer	2.07e-05	0.00018	CcSEcCtD
Tenofovir—Fatigue—Dexamethasone—hematologic cancer	2.07e-05	0.00018	CcSEcCtD
Tenofovir—Pruritus—Etoposide—hematologic cancer	2.06e-05	0.00018	CcSEcCtD
Tenofovir—Pain—Dexamethasone—hematologic cancer	2.05e-05	0.000179	CcSEcCtD
Tenofovir—Pain—Betamethasone—hematologic cancer	2.05e-05	0.000179	CcSEcCtD
Tenofovir—Nervous system disorder—Prednisone—hematologic cancer	2.05e-05	0.000178	CcSEcCtD
Tenofovir—Skin disorder—Prednisone—hematologic cancer	2.03e-05	0.000177	CcSEcCtD
Tenofovir—Nausea—Gemcitabine—hematologic cancer	2.03e-05	0.000177	CcSEcCtD
Tenofovir—Vomiting—Cisplatin—hematologic cancer	2.02e-05	0.000176	CcSEcCtD
Tenofovir—Hyperhidrosis—Prednisone—hematologic cancer	2.02e-05	0.000176	CcSEcCtD
Tenofovir—Mental disorder—Epirubicin—hematologic cancer	2.02e-05	0.000175	CcSEcCtD
Tenofovir—Rash—Cisplatin—hematologic cancer	2.01e-05	0.000175	CcSEcCtD
Tenofovir—Dermatitis—Cisplatin—hematologic cancer	2.01e-05	0.000175	CcSEcCtD
Tenofovir—Malnutrition—Epirubicin—hematologic cancer	2e-05	0.000174	CcSEcCtD
Tenofovir—Diarrhoea—Etoposide—hematologic cancer	2e-05	0.000174	CcSEcCtD
Tenofovir—Anorexia—Prednisone—hematologic cancer	1.99e-05	0.000173	CcSEcCtD
Tenofovir—Flatulence—Epirubicin—hematologic cancer	1.97e-05	0.000172	CcSEcCtD
Tenofovir—Gastrointestinal pain—Betamethasone—hematologic cancer	1.96e-05	0.000171	CcSEcCtD
Tenofovir—Gastrointestinal pain—Dexamethasone—hematologic cancer	1.96e-05	0.000171	CcSEcCtD
Tenofovir—Hypersensitivity—Triamcinolone—hematologic cancer	1.95e-05	0.00017	CcSEcCtD
Tenofovir—Back pain—Epirubicin—hematologic cancer	1.94e-05	0.000169	CcSEcCtD
Tenofovir—Dizziness—Etoposide—hematologic cancer	1.93e-05	0.000168	CcSEcCtD
Tenofovir—Immune system disorder—Doxorubicin—hematologic cancer	1.92e-05	0.000167	CcSEcCtD
Tenofovir—Mediastinal disorder—Doxorubicin—hematologic cancer	1.92e-05	0.000167	CcSEcCtD
Tenofovir—Musculoskeletal discomfort—Prednisone—hematologic cancer	1.9e-05	0.000166	CcSEcCtD
Tenofovir—Dizziness—Prednisolone—hematologic cancer	1.9e-05	0.000166	CcSEcCtD
Tenofovir—Asthenia—Triamcinolone—hematologic cancer	1.9e-05	0.000165	CcSEcCtD
Tenofovir—Body temperature increased—Dexamethasone—hematologic cancer	1.9e-05	0.000165	CcSEcCtD
Tenofovir—Body temperature increased—Betamethasone—hematologic cancer	1.9e-05	0.000165	CcSEcCtD
Tenofovir—Abdominal pain—Dexamethasone—hematologic cancer	1.9e-05	0.000165	CcSEcCtD
Tenofovir—Abdominal pain—Betamethasone—hematologic cancer	1.9e-05	0.000165	CcSEcCtD
Tenofovir—Nausea—Cisplatin—hematologic cancer	1.89e-05	0.000165	CcSEcCtD
Tenofovir—Insomnia—Prednisone—hematologic cancer	1.89e-05	0.000165	CcSEcCtD
Tenofovir—Pruritus—Triamcinolone—hematologic cancer	1.87e-05	0.000163	CcSEcCtD
Tenofovir—Mental disorder—Doxorubicin—hematologic cancer	1.87e-05	0.000162	CcSEcCtD
Tenofovir—Vomiting—Etoposide—hematologic cancer	1.85e-05	0.000161	CcSEcCtD
Tenofovir—Malnutrition—Doxorubicin—hematologic cancer	1.85e-05	0.000161	CcSEcCtD
Tenofovir—Dyspepsia—Prednisone—hematologic cancer	1.84e-05	0.00016	CcSEcCtD
Tenofovir—Rash—Etoposide—hematologic cancer	1.84e-05	0.00016	CcSEcCtD
Tenofovir—Dermatitis—Etoposide—hematologic cancer	1.84e-05	0.00016	CcSEcCtD
Tenofovir—Headache—Etoposide—hematologic cancer	1.83e-05	0.000159	CcSEcCtD
Tenofovir—Flatulence—Doxorubicin—hematologic cancer	1.83e-05	0.000159	CcSEcCtD
Tenofovir—Myalgia—Methotrexate—hematologic cancer	1.82e-05	0.000159	CcSEcCtD
Tenofovir—Arthralgia—Methotrexate—hematologic cancer	1.82e-05	0.000159	CcSEcCtD
Tenofovir—Chest pain—Methotrexate—hematologic cancer	1.82e-05	0.000159	CcSEcCtD
Tenofovir—Decreased appetite—Prednisone—hematologic cancer	1.82e-05	0.000158	CcSEcCtD
Tenofovir—Rash—Prednisolone—hematologic cancer	1.81e-05	0.000158	CcSEcCtD
Tenofovir—Dermatitis—Prednisolone—hematologic cancer	1.81e-05	0.000158	CcSEcCtD
Tenofovir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	1.81e-05	0.000157	CcSEcCtD
Tenofovir—Fatigue—Prednisone—hematologic cancer	1.8e-05	0.000157	CcSEcCtD
Tenofovir—Headache—Prednisolone—hematologic cancer	1.8e-05	0.000157	CcSEcCtD
Tenofovir—Back pain—Doxorubicin—hematologic cancer	1.79e-05	0.000156	CcSEcCtD
Tenofovir—Dizziness—Triamcinolone—hematologic cancer	1.75e-05	0.000152	CcSEcCtD
Tenofovir—Nausea—Etoposide—hematologic cancer	1.73e-05	0.000151	CcSEcCtD
Tenofovir—Asthenia—Betamethasone—hematologic cancer	1.72e-05	0.00015	CcSEcCtD
Tenofovir—Asthenia—Dexamethasone—hematologic cancer	1.72e-05	0.00015	CcSEcCtD
Tenofovir—Nervous system disorder—Methotrexate—hematologic cancer	1.71e-05	0.000149	CcSEcCtD
Tenofovir—Gastrointestinal pain—Prednisone—hematologic cancer	1.71e-05	0.000149	CcSEcCtD
Tenofovir—Nausea—Prednisolone—hematologic cancer	1.71e-05	0.000149	CcSEcCtD
Tenofovir—Arthralgia—Epirubicin—hematologic cancer	1.71e-05	0.000148	CcSEcCtD
Tenofovir—Myalgia—Epirubicin—hematologic cancer	1.71e-05	0.000148	CcSEcCtD
Tenofovir—Chest pain—Epirubicin—hematologic cancer	1.71e-05	0.000148	CcSEcCtD
Tenofovir—Anxiety—Epirubicin—hematologic cancer	1.7e-05	0.000148	CcSEcCtD
Tenofovir—Pruritus—Dexamethasone—hematologic cancer	1.7e-05	0.000148	CcSEcCtD
Tenofovir—Pruritus—Betamethasone—hematologic cancer	1.7e-05	0.000148	CcSEcCtD
Tenofovir—Skin disorder—Methotrexate—hematologic cancer	1.7e-05	0.000148	CcSEcCtD
Tenofovir—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	1.69e-05	0.000147	CcSEcCtD
Tenofovir—Hyperhidrosis—Methotrexate—hematologic cancer	1.69e-05	0.000147	CcSEcCtD
Tenofovir—Vomiting—Triamcinolone—hematologic cancer	1.68e-05	0.000146	CcSEcCtD
Tenofovir—Rash—Triamcinolone—hematologic cancer	1.67e-05	0.000145	CcSEcCtD
Tenofovir—Dermatitis—Triamcinolone—hematologic cancer	1.67e-05	0.000145	CcSEcCtD
Tenofovir—Anorexia—Methotrexate—hematologic cancer	1.67e-05	0.000145	CcSEcCtD
Tenofovir—Headache—Triamcinolone—hematologic cancer	1.66e-05	0.000144	CcSEcCtD
Tenofovir—Abdominal pain—Prednisone—hematologic cancer	1.65e-05	0.000144	CcSEcCtD
Tenofovir—Body temperature increased—Prednisone—hematologic cancer	1.65e-05	0.000144	CcSEcCtD
Tenofovir—Diarrhoea—Dexamethasone—hematologic cancer	1.64e-05	0.000143	CcSEcCtD
Tenofovir—Diarrhoea—Betamethasone—hematologic cancer	1.64e-05	0.000143	CcSEcCtD
Tenofovir—Nervous system disorder—Epirubicin—hematologic cancer	1.6e-05	0.00014	CcSEcCtD
Tenofovir—Musculoskeletal discomfort—Methotrexate—hematologic cancer	1.59e-05	0.000139	CcSEcCtD
Tenofovir—Skin disorder—Epirubicin—hematologic cancer	1.59e-05	0.000138	CcSEcCtD
Tenofovir—Dizziness—Dexamethasone—hematologic cancer	1.59e-05	0.000138	CcSEcCtD
Tenofovir—Dizziness—Betamethasone—hematologic cancer	1.59e-05	0.000138	CcSEcCtD
Tenofovir—Hyperhidrosis—Epirubicin—hematologic cancer	1.58e-05	0.000138	CcSEcCtD
Tenofovir—Insomnia—Methotrexate—hematologic cancer	1.58e-05	0.000137	CcSEcCtD
Tenofovir—Arthralgia—Doxorubicin—hematologic cancer	1.58e-05	0.000137	CcSEcCtD
Tenofovir—Myalgia—Doxorubicin—hematologic cancer	1.58e-05	0.000137	CcSEcCtD
Tenofovir—Chest pain—Doxorubicin—hematologic cancer	1.58e-05	0.000137	CcSEcCtD
Tenofovir—Anxiety—Doxorubicin—hematologic cancer	1.57e-05	0.000137	CcSEcCtD
Tenofovir—Nausea—Triamcinolone—hematologic cancer	1.57e-05	0.000137	CcSEcCtD
Tenofovir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	1.57e-05	0.000136	CcSEcCtD
Tenofovir—Anorexia—Epirubicin—hematologic cancer	1.56e-05	0.000136	CcSEcCtD
Tenofovir—Dyspnoea—Methotrexate—hematologic cancer	1.56e-05	0.000136	CcSEcCtD
Tenofovir—NME2—Metabolism—ABCB1—hematologic cancer	1.55e-05	0.000297	CbGpPWpGaD
Tenofovir—ABCC4—Transmembrane transport of small molecules—ADCY7—hematologic cancer	1.54e-05	0.000297	CbGpPWpGaD
Tenofovir—Hypersensitivity—Prednisone—hematologic cancer	1.54e-05	0.000134	CcSEcCtD
Tenofovir—Dyspepsia—Methotrexate—hematologic cancer	1.54e-05	0.000134	CcSEcCtD
Tenofovir—ABCC4—Transmembrane transport of small molecules—NUP214—hematologic cancer	1.53e-05	0.000295	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—H3F3A—hematologic cancer	1.53e-05	0.000294	CbGpPWpGaD
Tenofovir—Vomiting—Betamethasone—hematologic cancer	1.53e-05	0.000133	CcSEcCtD
Tenofovir—Vomiting—Dexamethasone—hematologic cancer	1.53e-05	0.000133	CcSEcCtD
Tenofovir—Decreased appetite—Methotrexate—hematologic cancer	1.52e-05	0.000132	CcSEcCtD
Tenofovir—ABCC4—Hemostasis—GATA3—hematologic cancer	1.52e-05	0.000291	CbGpPWpGaD
Tenofovir—ABCC4—Platelet activation, signaling and aggregation—PIK3CG—hematologic cancer	1.51e-05	0.000291	CbGpPWpGaD
Tenofovir—Rash—Dexamethasone—hematologic cancer	1.51e-05	0.000132	CcSEcCtD
Tenofovir—Rash—Betamethasone—hematologic cancer	1.51e-05	0.000132	CcSEcCtD
Tenofovir—Dermatitis—Betamethasone—hematologic cancer	1.51e-05	0.000132	CcSEcCtD
Tenofovir—Dermatitis—Dexamethasone—hematologic cancer	1.51e-05	0.000132	CcSEcCtD
Tenofovir—ABCC4—Hemostasis—HSPA5—hematologic cancer	1.51e-05	0.00029	CbGpPWpGaD
Tenofovir—Gastrointestinal disorder—Methotrexate—hematologic cancer	1.51e-05	0.000131	CcSEcCtD
Tenofovir—Fatigue—Methotrexate—hematologic cancer	1.51e-05	0.000131	CcSEcCtD
Tenofovir—Headache—Betamethasone—hematologic cancer	1.5e-05	0.000131	CcSEcCtD
Tenofovir—Headache—Dexamethasone—hematologic cancer	1.5e-05	0.000131	CcSEcCtD
Tenofovir—NME2—Metabolism—GSTM1—hematologic cancer	1.5e-05	0.000289	CbGpPWpGaD
Tenofovir—NME2—Metabolism—NCOR1—hematologic cancer	1.5e-05	0.000289	CbGpPWpGaD
Tenofovir—ABCC4—Transmembrane transport of small molecules—ABCG2—hematologic cancer	1.5e-05	0.000289	CbGpPWpGaD
Tenofovir—CYP1A2—Biological oxidations—UGT1A1—hematologic cancer	1.5e-05	0.000288	CbGpPWpGaD
Tenofovir—Asthenia—Prednisone—hematologic cancer	1.5e-05	0.000131	CcSEcCtD
Tenofovir—Pain—Methotrexate—hematologic cancer	1.49e-05	0.00013	CcSEcCtD
Tenofovir—AK2—Metabolism—CREBBP—hematologic cancer	1.49e-05	0.000287	CbGpPWpGaD
Tenofovir—Musculoskeletal discomfort—Epirubicin—hematologic cancer	1.49e-05	0.00013	CcSEcCtD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor—MAP2K1—hematologic cancer	1.49e-05	0.000286	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—PRKCZ—hematologic cancer	1.49e-05	0.000286	CbGpPWpGaD
Tenofovir—NME1—Metabolism—CD44—hematologic cancer	1.49e-05	0.000285	CbGpPWpGaD
Tenofovir—NME1—Metabolism—NQO1—hematologic cancer	1.49e-05	0.000285	CbGpPWpGaD
Tenofovir—Nervous system disorder—Doxorubicin—hematologic cancer	1.48e-05	0.000129	CcSEcCtD
Tenofovir—CYP1A2—Metapathway biotransformation—UGT1A1—hematologic cancer	1.48e-05	0.000284	CbGpPWpGaD
Tenofovir—Pruritus—Prednisone—hematologic cancer	1.48e-05	0.000129	CcSEcCtD
Tenofovir—Insomnia—Epirubicin—hematologic cancer	1.48e-05	0.000129	CcSEcCtD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—PHYH—hematologic cancer	1.48e-05	0.000284	CbGpPWpGaD
Tenofovir—Skin disorder—Doxorubicin—hematologic cancer	1.47e-05	0.000128	CcSEcCtD
Tenofovir—CYP1A2—Phase II conjugation—GSTP1—hematologic cancer	1.47e-05	0.000282	CbGpPWpGaD
Tenofovir—SLC22A6—Transmembrane transport of small molecules—SLC22A1—hematologic cancer	1.47e-05	0.000282	CbGpPWpGaD
Tenofovir—Hyperhidrosis—Doxorubicin—hematologic cancer	1.46e-05	0.000127	CcSEcCtD
Tenofovir—Dyspnoea—Epirubicin—hematologic cancer	1.46e-05	0.000127	CcSEcCtD
Tenofovir—Anorexia—Doxorubicin—hematologic cancer	1.44e-05	0.000125	CcSEcCtD
Tenofovir—Dyspepsia—Epirubicin—hematologic cancer	1.44e-05	0.000125	CcSEcCtD
Tenofovir—Diarrhoea—Prednisone—hematologic cancer	1.43e-05	0.000124	CcSEcCtD
Tenofovir—Gastrointestinal pain—Methotrexate—hematologic cancer	1.43e-05	0.000124	CcSEcCtD
Tenofovir—Nausea—Dexamethasone—hematologic cancer	1.43e-05	0.000124	CcSEcCtD
Tenofovir—Nausea—Betamethasone—hematologic cancer	1.43e-05	0.000124	CcSEcCtD
Tenofovir—Decreased appetite—Epirubicin—hematologic cancer	1.42e-05	0.000124	CcSEcCtD
Tenofovir—ABCC2—Transmembrane transport of small molecules—SLC22A1—hematologic cancer	1.42e-05	0.000273	CbGpPWpGaD
Tenofovir—AK2—Metabolism—PIK3CD—hematologic cancer	1.41e-05	0.000272	CbGpPWpGaD
Tenofovir—Gastrointestinal disorder—Epirubicin—hematologic cancer	1.41e-05	0.000123	CcSEcCtD
Tenofovir—Fatigue—Epirubicin—hematologic cancer	1.41e-05	0.000123	CcSEcCtD
Tenofovir—NME1—Metabolism—CYCS—hematologic cancer	1.41e-05	0.00027	CbGpPWpGaD
Tenofovir—Pain—Epirubicin—hematologic cancer	1.4e-05	0.000122	CcSEcCtD
Tenofovir—AK2—Metabolism—ALB—hematologic cancer	1.4e-05	0.000268	CbGpPWpGaD
Tenofovir—NME1—Metabolism—HSP90AA1—hematologic cancer	1.4e-05	0.000268	CbGpPWpGaD
Tenofovir—SLC22A8—Transmembrane transport of small molecules—TFRC—hematologic cancer	1.4e-05	0.000268	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—HDAC2—hematologic cancer	1.39e-05	0.000266	CbGpPWpGaD
Tenofovir—SLC22A6—Transmembrane transport of small molecules—NUP98—hematologic cancer	1.38e-05	0.000266	CbGpPWpGaD
Tenofovir—Dizziness—Prednisone—hematologic cancer	1.38e-05	0.00012	CcSEcCtD
Tenofovir—Abdominal pain—Methotrexate—hematologic cancer	1.38e-05	0.00012	CcSEcCtD
Tenofovir—Body temperature increased—Methotrexate—hematologic cancer	1.38e-05	0.00012	CcSEcCtD
Tenofovir—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	1.38e-05	0.00012	CcSEcCtD
Tenofovir—ABCC4—Hemostasis—CD44—hematologic cancer	1.37e-05	0.000263	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—ITGA4—hematologic cancer	1.37e-05	0.000263	CbGpPWpGaD
Tenofovir—Insomnia—Doxorubicin—hematologic cancer	1.37e-05	0.000119	CcSEcCtD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—SMPD3—hematologic cancer	1.35e-05	0.000259	CbGpPWpGaD
Tenofovir—Dyspnoea—Doxorubicin—hematologic cancer	1.35e-05	0.000117	CcSEcCtD
Tenofovir—CYP1A2—Phase II conjugation—GSTM1—hematologic cancer	1.35e-05	0.000259	CbGpPWpGaD
Tenofovir—SLC22A6—Transmembrane transport of small molecules—ADCY7—hematologic cancer	1.34e-05	0.000258	CbGpPWpGaD
Tenofovir—ABCC2—Transmembrane transport of small molecules—NUP98—hematologic cancer	1.34e-05	0.000258	CbGpPWpGaD
Tenofovir—ABCC4—Transmembrane transport of small molecules—TFRC—hematologic cancer	1.34e-05	0.000257	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—IL3—hematologic cancer	1.34e-05	0.000257	CbGpPWpGaD
Tenofovir—Gastrointestinal pain—Epirubicin—hematologic cancer	1.34e-05	0.000116	CcSEcCtD
Tenofovir—AK2—Metabolism—PIK3R1—hematologic cancer	1.34e-05	0.000257	CbGpPWpGaD
Tenofovir—SLC22A6—Transmembrane transport of small molecules—NUP214—hematologic cancer	1.33e-05	0.000256	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—hematologic cancer	1.33e-05	0.000256	CbGpPWpGaD
Tenofovir—Dyspepsia—Doxorubicin—hematologic cancer	1.33e-05	0.000116	CcSEcCtD
Tenofovir—ABCC4—Platelet activation, signaling and aggregation—PIK3CD—hematologic cancer	1.33e-05	0.000256	CbGpPWpGaD
Tenofovir—Vomiting—Prednisone—hematologic cancer	1.33e-05	0.000116	CcSEcCtD
Tenofovir—ABCC4—Hemostasis—IFNA1—hematologic cancer	1.33e-05	0.000255	CbGpPWpGaD
Tenofovir—NME2—Metabolism—MTHFR—hematologic cancer	1.33e-05	0.000255	CbGpPWpGaD
Tenofovir—CYP1A2—Tryptophan metabolism—MDM2—hematologic cancer	1.32e-05	0.000255	CbGpPWpGaD
Tenofovir—Rash—Prednisone—hematologic cancer	1.32e-05	0.000115	CcSEcCtD
Tenofovir—Dermatitis—Prednisone—hematologic cancer	1.32e-05	0.000115	CcSEcCtD
Tenofovir—Decreased appetite—Doxorubicin—hematologic cancer	1.32e-05	0.000114	CcSEcCtD
Tenofovir—ABCC4—Hemostasis—PTPN1—hematologic cancer	1.31e-05	0.000253	CbGpPWpGaD
Tenofovir—ABCC4—Platelet activation, signaling and aggregation—ALB—hematologic cancer	1.31e-05	0.000252	CbGpPWpGaD
Tenofovir—Headache—Prednisone—hematologic cancer	1.31e-05	0.000114	CcSEcCtD
Tenofovir—SLC22A6—Transmembrane transport of small molecules—ABCG2—hematologic cancer	1.31e-05	0.000251	CbGpPWpGaD
Tenofovir—Gastrointestinal disorder—Doxorubicin—hematologic cancer	1.31e-05	0.000114	CcSEcCtD
Tenofovir—Fatigue—Doxorubicin—hematologic cancer	1.3e-05	0.000113	CcSEcCtD
Tenofovir—ABCC2—Transmembrane transport of small molecules—ADCY7—hematologic cancer	1.3e-05	0.00025	CbGpPWpGaD
Tenofovir—CYP1A2—Biological oxidations—MTR—hematologic cancer	1.3e-05	0.00025	CbGpPWpGaD
Tenofovir—Pain—Doxorubicin—hematologic cancer	1.29e-05	0.000113	CcSEcCtD
Tenofovir—ABCC4—Hemostasis—RASGRP1—hematologic cancer	1.29e-05	0.000249	CbGpPWpGaD
Tenofovir—ABCC2—Transmembrane transport of small molecules—NUP214—hematologic cancer	1.29e-05	0.000248	CbGpPWpGaD
Tenofovir—Body temperature increased—Epirubicin—hematologic cancer	1.29e-05	0.000112	CcSEcCtD
Tenofovir—Abdominal pain—Epirubicin—hematologic cancer	1.29e-05	0.000112	CcSEcCtD
Tenofovir—ABCC4—Hemostasis—SYK—hematologic cancer	1.29e-05	0.000248	CbGpPWpGaD
Tenofovir—Hypersensitivity—Methotrexate—hematologic cancer	1.29e-05	0.000112	CcSEcCtD
Tenofovir—ABCC2—Transmembrane transport of small molecules—ABCG2—hematologic cancer	1.27e-05	0.000243	CbGpPWpGaD
Tenofovir—ABCC4—Platelet activation, signaling and aggregation—PIK3R1—hematologic cancer	1.26e-05	0.000241	CbGpPWpGaD
Tenofovir—Asthenia—Methotrexate—hematologic cancer	1.25e-05	0.000109	CcSEcCtD
Tenofovir—Nausea—Prednisone—hematologic cancer	1.24e-05	0.000108	CcSEcCtD
Tenofovir—NME1—Metabolism—GSTP1—hematologic cancer	1.24e-05	0.000238	CbGpPWpGaD
Tenofovir—CYP1A2—Biological oxidations—GSTT1—hematologic cancer	1.24e-05	0.000238	CbGpPWpGaD
Tenofovir—Gastrointestinal pain—Doxorubicin—hematologic cancer	1.24e-05	0.000108	CcSEcCtD
Tenofovir—ABCC4—Hemostasis—IFNA2—hematologic cancer	1.24e-05	0.000237	CbGpPWpGaD
Tenofovir—Pruritus—Methotrexate—hematologic cancer	1.24e-05	0.000108	CcSEcCtD
Tenofovir—AK2—Metabolism—PIK3CB—hematologic cancer	1.23e-05	0.000237	CbGpPWpGaD
Tenofovir—ABCC4—Platelet activation, signaling and aggregation—JAK2—hematologic cancer	1.22e-05	0.000235	CbGpPWpGaD
Tenofovir—ABCC4—Ectoderm Differentiation—MYC—hematologic cancer	1.21e-05	0.000233	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—hematologic cancer	1.21e-05	0.000232	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—hematologic cancer	1.21e-05	0.000232	CbGpPWpGaD
Tenofovir—Hypersensitivity—Epirubicin—hematologic cancer	1.2e-05	0.000105	CcSEcCtD
Tenofovir—SLC22A8—SLC-mediated transmembrane transport—ALB—hematologic cancer	1.2e-05	0.000231	CbGpPWpGaD
Tenofovir—Abdominal pain—Doxorubicin—hematologic cancer	1.2e-05	0.000104	CcSEcCtD
Tenofovir—Body temperature increased—Doxorubicin—hematologic cancer	1.2e-05	0.000104	CcSEcCtD
Tenofovir—Diarrhoea—Methotrexate—hematologic cancer	1.2e-05	0.000104	CcSEcCtD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—hematologic cancer	1.19e-05	0.000228	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—hematologic cancer	1.18e-05	0.000227	CbGpPWpGaD
Tenofovir—Asthenia—Epirubicin—hematologic cancer	1.17e-05	0.000102	CcSEcCtD
Tenofovir—NME1—Metabolism—ABCB1—hematologic cancer	1.17e-05	0.000225	CbGpPWpGaD
Tenofovir—SLC22A8—Transmembrane transport of small molecules—CYCS—hematologic cancer	1.17e-05	0.000225	CbGpPWpGaD
Tenofovir—SLC22A6—Transmembrane transport of small molecules—TFRC—hematologic cancer	1.17e-05	0.000224	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—GRB2—hematologic cancer	1.16e-05	0.000223	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—PDGFA—hematologic cancer	1.16e-05	0.000223	CbGpPWpGaD
Tenofovir—ABCC4—Platelet activation, signaling and aggregation—PIK3CB—hematologic cancer	1.16e-05	0.000223	CbGpPWpGaD
Tenofovir—ABCC4—NRF2 pathway—TGFB1—hematologic cancer	1.16e-05	0.000222	CbGpPWpGaD
Tenofovir—Pruritus—Epirubicin—hematologic cancer	1.16e-05	0.000101	CcSEcCtD
Tenofovir—Dizziness—Methotrexate—hematologic cancer	1.16e-05	0.000101	CcSEcCtD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—hematologic cancer	1.15e-05	0.000221	CbGpPWpGaD
Tenofovir—NME1—Metabolism—GSTM1—hematologic cancer	1.14e-05	0.000219	CbGpPWpGaD
Tenofovir—NME1—Metabolism—NCOR1—hematologic cancer	1.14e-05	0.000219	CbGpPWpGaD
Tenofovir—ABCC2—Transmembrane transport of small molecules—TFRC—hematologic cancer	1.13e-05	0.000217	CbGpPWpGaD
Tenofovir—ABCC4—Transmembrane transport of small molecules—CYCS—hematologic cancer	1.12e-05	0.000216	CbGpPWpGaD
Tenofovir—Diarrhoea—Epirubicin—hematologic cancer	1.12e-05	9.73e-05	CcSEcCtD
Tenofovir—ABCC4—Hemostasis—ABL1—hematologic cancer	1.12e-05	0.000215	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—hematologic cancer	1.12e-05	0.000214	CbGpPWpGaD
Tenofovir—NME2—Metabolism—PIK3CG—hematologic cancer	1.12e-05	0.000214	CbGpPWpGaD
Tenofovir—Hypersensitivity—Doxorubicin—hematologic cancer	1.11e-05	9.7e-05	CcSEcCtD
Tenofovir—Vomiting—Methotrexate—hematologic cancer	1.11e-05	9.67e-05	CcSEcCtD
Tenofovir—Rash—Methotrexate—hematologic cancer	1.1e-05	9.59e-05	CcSEcCtD
Tenofovir—Dermatitis—Methotrexate—hematologic cancer	1.1e-05	9.58e-05	CcSEcCtD
Tenofovir—Headache—Methotrexate—hematologic cancer	1.09e-05	9.52e-05	CcSEcCtD
Tenofovir—Asthenia—Doxorubicin—hematologic cancer	1.09e-05	9.44e-05	CcSEcCtD
Tenofovir—Dizziness—Epirubicin—hematologic cancer	1.08e-05	9.41e-05	CcSEcCtD
Tenofovir—Pruritus—Doxorubicin—hematologic cancer	1.07e-05	9.31e-05	CcSEcCtD
Tenofovir—AK2—Metabolism—PTEN—hematologic cancer	1.07e-05	0.000205	CbGpPWpGaD
Tenofovir—ABCC4—Platelet activation, signaling and aggregation—IL2—hematologic cancer	1.07e-05	0.000205	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor—EP300—hematologic cancer	1.06e-05	0.000204	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—hematologic cancer	1.06e-05	0.000204	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—HGF—hematologic cancer	1.05e-05	0.000202	CbGpPWpGaD
Tenofovir—Vomiting—Epirubicin—hematologic cancer	1.04e-05	9.05e-05	CcSEcCtD
Tenofovir—ABCC4—Hemostasis—CSF2—hematologic cancer	1.04e-05	0.0002	CbGpPWpGaD
Tenofovir—Nausea—Methotrexate—hematologic cancer	1.04e-05	9.03e-05	CcSEcCtD
Tenofovir—Diarrhoea—Doxorubicin—hematologic cancer	1.04e-05	9.01e-05	CcSEcCtD
Tenofovir—NME2—Metabolism—CREBBP—hematologic cancer	1.03e-05	0.000199	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor—SRC—hematologic cancer	1.03e-05	0.000198	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor Pathway—SRC—hematologic cancer	1.03e-05	0.000198	CbGpPWpGaD
Tenofovir—Rash—Epirubicin—hematologic cancer	1.03e-05	8.97e-05	CcSEcCtD
Tenofovir—Dermatitis—Epirubicin—hematologic cancer	1.03e-05	8.96e-05	CcSEcCtD
Tenofovir—Headache—Epirubicin—hematologic cancer	1.02e-05	8.91e-05	CcSEcCtD
Tenofovir—AK2—Metabolism—EP300—hematologic cancer	1.02e-05	0.000195	CbGpPWpGaD
Tenofovir—NME1—Metabolism—MTHFR—hematologic cancer	1.01e-05	0.000193	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—hematologic cancer	1.01e-05	0.000193	CbGpPWpGaD
Tenofovir—SLC22A6—SLC-mediated transmembrane transport—ALB—hematologic cancer	1e-05	0.000193	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—PRKCG—hematologic cancer	1e-05	0.000193	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—JAK1—hematologic cancer	1e-05	0.000193	CbGpPWpGaD
Tenofovir—Dizziness—Doxorubicin—hematologic cancer	1e-05	8.7e-05	CcSEcCtD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—hematologic cancer	9.94e-06	0.000191	CbGpPWpGaD
Tenofovir—NME2—Metabolism—PIK3CD—hematologic cancer	9.81e-06	0.000188	CbGpPWpGaD
Tenofovir—SLC22A6—Transmembrane transport of small molecules—CYCS—hematologic cancer	9.78e-06	0.000188	CbGpPWpGaD
Tenofovir—SLC22A8—Transmembrane transport of small molecules—ABCB1—hematologic cancer	9.78e-06	0.000188	CbGpPWpGaD
Tenofovir—ABCC2—NRF2 pathway—TGFB1—hematologic cancer	9.77e-06	0.000188	CbGpPWpGaD
Tenofovir—Nausea—Epirubicin—hematologic cancer	9.71e-06	8.45e-05	CcSEcCtD
Tenofovir—NME2—Metabolism—ALB—hematologic cancer	9.68e-06	0.000186	CbGpPWpGaD
Tenofovir—Vomiting—Doxorubicin—hematologic cancer	9.62e-06	8.37e-05	CcSEcCtD
Tenofovir—Rash—Doxorubicin—hematologic cancer	9.54e-06	8.3e-05	CcSEcCtD
Tenofovir—Dermatitis—Doxorubicin—hematologic cancer	9.53e-06	8.29e-05	CcSEcCtD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—GBA—hematologic cancer	9.52e-06	0.000183	CbGpPWpGaD
Tenofovir—Headache—Doxorubicin—hematologic cancer	9.48e-06	8.25e-05	CcSEcCtD
Tenofovir—ABCC2—Transmembrane transport of small molecules—CYCS—hematologic cancer	9.47e-06	0.000182	CbGpPWpGaD
Tenofovir—ABCC4—Transmembrane transport of small molecules—ABCB1—hematologic cancer	9.37e-06	0.00018	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—IL2RA—hematologic cancer	9.37e-06	0.00018	CbGpPWpGaD
Tenofovir—ABCC4—Platelet activation, signaling and aggregation—SRC—hematologic cancer	9.3e-06	0.000179	CbGpPWpGaD
Tenofovir—NME2—Metabolism—PIK3R1—hematologic cancer	9.26e-06	0.000178	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor—MYC—hematologic cancer	9.26e-06	0.000178	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—hematologic cancer	9.23e-06	0.000177	CbGpPWpGaD
Tenofovir—ABCC4—Platelet activation, signaling and aggregation—VEGFA—hematologic cancer	9.06e-06	0.000174	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—PDGFB—hematologic cancer	9.04e-06	0.000174	CbGpPWpGaD
Tenofovir—Nausea—Doxorubicin—hematologic cancer	8.99e-06	7.82e-05	CcSEcCtD
Tenofovir—ABCC4—Hemostasis—CDK2—hematologic cancer	8.77e-06	0.000169	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—hematologic cancer	8.62e-06	0.000166	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor—TNF—hematologic cancer	8.62e-06	0.000166	CbGpPWpGaD
Tenofovir—CYP1A2—Biological oxidations—GSTP1—hematologic cancer	8.58e-06	0.000165	CbGpPWpGaD
Tenofovir—ABCC4—Platelet activation, signaling and aggregation—MAPK3—hematologic cancer	8.57e-06	0.000165	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—hematologic cancer	8.55e-06	0.000164	CbGpPWpGaD
Tenofovir—NME2—Metabolism—PIK3CB—hematologic cancer	8.55e-06	0.000164	CbGpPWpGaD
Tenofovir—CYP1A2—Metapathway biotransformation—GSTP1—hematologic cancer	8.47e-06	0.000163	CbGpPWpGaD
Tenofovir—NME1—Metabolism—PIK3CG—hematologic cancer	8.45e-06	0.000162	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—MAPK14—hematologic cancer	8.42e-06	0.000162	CbGpPWpGaD
Tenofovir—ABCC4—Platelet activation, signaling and aggregation—TGFB1—hematologic cancer	8.31e-06	0.00016	CbGpPWpGaD
Tenofovir—SLC22A6—Transmembrane transport of small molecules—ABCB1—hematologic cancer	8.16e-06	0.000157	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—FN1—hematologic cancer	8.16e-06	0.000157	CbGpPWpGaD
Tenofovir—ABCC2—Transmembrane transport of small molecules—ABCB1—hematologic cancer	7.9e-06	0.000152	CbGpPWpGaD
Tenofovir—CYP1A2—Biological oxidations—GSTM1—hematologic cancer	7.89e-06	0.000152	CbGpPWpGaD
Tenofovir—NME1—Metabolism—CREBBP—hematologic cancer	7.84e-06	0.000151	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—PIK3CG—hematologic cancer	7.81e-06	0.00015	CbGpPWpGaD
Tenofovir—CYP1A2—Metapathway biotransformation—GSTM1—hematologic cancer	7.78e-06	0.000149	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—FHL2—hematologic cancer	7.76e-06	0.000149	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—PTPN11—hematologic cancer	7.67e-06	0.000147	CbGpPWpGaD
Tenofovir—AK2—Metabolism—PIK3CA—hematologic cancer	7.52e-06	0.000144	CbGpPWpGaD
Tenofovir—NME1—Metabolism—PIK3CD—hematologic cancer	7.43e-06	0.000143	CbGpPWpGaD
Tenofovir—NME2—Metabolism—PTEN—hematologic cancer	7.39e-06	0.000142	CbGpPWpGaD
Tenofovir—NME1—Metabolism—ALB—hematologic cancer	7.34e-06	0.000141	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—hematologic cancer	7.27e-06	0.00014	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—CREBBP—hematologic cancer	7.24e-06	0.000139	CbGpPWpGaD
Tenofovir—ABCC4—Platelet activation, signaling and aggregation—PIK3CA—hematologic cancer	7.07e-06	0.000136	CbGpPWpGaD
Tenofovir—NME2—Metabolism—EP300—hematologic cancer	7.04e-06	0.000135	CbGpPWpGaD
Tenofovir—NME1—Metabolism—PIK3R1—hematologic cancer	7.02e-06	0.000135	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—PIK3CD—hematologic cancer	6.86e-06	0.000132	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—ARNTL—hematologic cancer	6.78e-06	0.00013	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—ALB—hematologic cancer	6.77e-06	0.00013	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—PHYH—hematologic cancer	6.58e-06	0.000126	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—GMPS—hematologic cancer	6.58e-06	0.000126	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—FTCD—hematologic cancer	6.58e-06	0.000126	CbGpPWpGaD
Tenofovir—SLC22A8—Transmembrane transport of small molecules—CREBBP—hematologic cancer	6.53e-06	0.000126	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—NCOR2—hematologic cancer	6.51e-06	0.000125	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—PIK3R1—hematologic cancer	6.48e-06	0.000124	CbGpPWpGaD
Tenofovir—NME1—Metabolism—PIK3CB—hematologic cancer	6.48e-06	0.000124	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—JAK2—hematologic cancer	6.3e-06	0.000121	CbGpPWpGaD
Tenofovir—ABCC4—Transmembrane transport of small molecules—CREBBP—hematologic cancer	6.26e-06	0.00012	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—IDH1—hematologic cancer	6.2e-06	0.000119	CbGpPWpGaD
Tenofovir—AK2—Metabolism—AKT1—hematologic cancer	6.14e-06	0.000118	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—ABCC3—hematologic cancer	6.13e-06	0.000118	CbGpPWpGaD
Tenofovir—SLC22A8—Transmembrane transport of small molecules—ALB—hematologic cancer	6.12e-06	0.000117	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—SMPD3—hematologic cancer	6.02e-06	0.000116	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—SPHK1—hematologic cancer	6e-06	0.000115	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—PIK3CB—hematologic cancer	5.98e-06	0.000115	CbGpPWpGaD
Tenofovir—ABCC4—Transmembrane transport of small molecules—ALB—hematologic cancer	5.86e-06	0.000113	CbGpPWpGaD
Tenofovir—ABCC4—Platelet activation, signaling and aggregation—AKT1—hematologic cancer	5.78e-06	0.000111	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—CRABP1—hematologic cancer	5.61e-06	0.000108	CbGpPWpGaD
Tenofovir—NME1—Metabolism—PTEN—hematologic cancer	5.6e-06	0.000108	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—IL2—hematologic cancer	5.49e-06	0.000106	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—ALOX5—hematologic cancer	5.47e-06	0.000105	CbGpPWpGaD
Tenofovir—SLC22A6—Transmembrane transport of small molecules—CREBBP—hematologic cancer	5.45e-06	0.000105	CbGpPWpGaD
Tenofovir—NME1—Metabolism—EP300—hematologic cancer	5.34e-06	0.000103	CbGpPWpGaD
Tenofovir—ABCC2—Transmembrane transport of small molecules—CREBBP—hematologic cancer	5.28e-06	0.000101	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—B3GAT1—hematologic cancer	5.26e-06	0.000101	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—ASNS—hematologic cancer	5.26e-06	0.000101	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—DCK—hematologic cancer	5.26e-06	0.000101	CbGpPWpGaD
Tenofovir—NME2—Metabolism—PIK3CA—hematologic cancer	5.21e-06	0.0001	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—NCOA3—hematologic cancer	5.14e-06	9.87e-05	CbGpPWpGaD
Tenofovir—SLC22A6—Transmembrane transport of small molecules—ALB—hematologic cancer	5.1e-06	9.81e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—HDC—hematologic cancer	4.98e-06	9.58e-05	CbGpPWpGaD
Tenofovir—ABCC2—Transmembrane transport of small molecules—ALB—hematologic cancer	4.94e-06	9.5e-05	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—EP300—hematologic cancer	4.93e-06	9.47e-05	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—SRC—hematologic cancer	4.79e-06	9.21e-05	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—VEGFA—hematologic cancer	4.67e-06	8.97e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—SDC1—hematologic cancer	4.65e-06	8.93e-05	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—NRAS—hematologic cancer	4.61e-06	8.86e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—CDA—hematologic cancer	4.56e-06	8.76e-05	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—MAPK3—hematologic cancer	4.42e-06	8.48e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—PC—hematologic cancer	4.39e-06	8.43e-05	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—TGFB1—hematologic cancer	4.28e-06	8.23e-05	CbGpPWpGaD
Tenofovir—NME2—Metabolism—AKT1—hematologic cancer	4.26e-06	8.18e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—GBA—hematologic cancer	4.24e-06	8.14e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—SLC35B2—hematologic cancer	4.24e-06	8.14e-05	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—KRAS—hematologic cancer	3.97e-06	7.62e-05	CbGpPWpGaD
Tenofovir—NME1—Metabolism—PIK3CA—hematologic cancer	3.95e-06	7.59e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—MTAP—hematologic cancer	3.88e-06	7.45e-05	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—PIK3CA—hematologic cancer	3.65e-06	7e-05	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—TP53—hematologic cancer	3.53e-06	6.78e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—FHL2—hematologic cancer	3.46e-06	6.64e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—AGRN—hematologic cancer	3.39e-06	6.51e-05	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—HRAS—hematologic cancer	3.37e-06	6.48e-05	CbGpPWpGaD
Tenofovir—NME1—Metabolism—AKT1—hematologic cancer	3.23e-06	6.2e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—HMMR—hematologic cancer	3.21e-06	6.17e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—IDH2—hematologic cancer	3.21e-06	6.17e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	3.03e-06	5.82e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—ARNTL—hematologic cancer	3.02e-06	5.8e-05	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—AKT1—hematologic cancer	2.98e-06	5.72e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—CA9—hematologic cancer	2.94e-06	5.64e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—ACP5—hematologic cancer	2.94e-06	5.64e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—NCOR2—hematologic cancer	2.9e-06	5.57e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—IDH1—hematologic cancer	2.76e-06	5.31e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—TXN—hematologic cancer	2.73e-06	5.25e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—ABCC3—hematologic cancer	2.73e-06	5.25e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—GSTO1—hematologic cancer	2.73e-06	5.25e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—SPHK1—hematologic cancer	2.67e-06	5.13e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—UGT1A1—hematologic cancer	2.57e-06	4.93e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—SLC22A1—hematologic cancer	2.5e-06	4.8e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—CRABP1—hematologic cancer	2.5e-06	4.8e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—ALOX5—hematologic cancer	2.43e-06	4.68e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—NUP98—hematologic cancer	2.36e-06	4.53e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—ADCY7—hematologic cancer	2.29e-06	4.4e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—NCOA3—hematologic cancer	2.29e-06	4.4e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—NUP214—hematologic cancer	2.27e-06	4.37e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	2.25e-06	4.32e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—MTR—hematologic cancer	2.23e-06	4.28e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—ABCG2—hematologic cancer	2.23e-06	4.28e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—ENO2—hematologic cancer	2.18e-06	4.19e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—GSTT1—hematologic cancer	2.12e-06	4.07e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	2.09e-06	4.01e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—SDC1—hematologic cancer	2.07e-06	3.98e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	1.98e-06	3.8e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	1.95e-06	3.75e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	1.87e-06	3.59e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—NQO1—hematologic cancer	1.76e-06	3.38e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—CD44—hematologic cancer	1.76e-06	3.38e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	1.72e-06	3.31e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—CYCS—hematologic cancer	1.67e-06	3.2e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—HSP90AA1—hematologic cancer	1.65e-06	3.18e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	1.49e-06	2.86e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—GSTP1—hematologic cancer	1.47e-06	2.82e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	1.42e-06	2.73e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—ABCB1—hematologic cancer	1.39e-06	2.67e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—NCOR1—hematologic cancer	1.35e-06	2.59e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—GSTM1—hematologic cancer	1.35e-06	2.59e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—MTHFR—hematologic cancer	1.19e-06	2.29e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.05e-06	2.02e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—PIK3CG—hematologic cancer	1e-06	1.92e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—CREBBP—hematologic cancer	9.29e-07	1.78e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—PIK3CD—hematologic cancer	8.81e-07	1.69e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—ALB—hematologic cancer	8.69e-07	1.67e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—PIK3R1—hematologic cancer	8.31e-07	1.6e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—PIK3CB—hematologic cancer	7.68e-07	1.47e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—PTEN—hematologic cancer	6.63e-07	1.27e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—EP300—hematologic cancer	6.32e-07	1.22e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—PIK3CA—hematologic cancer	4.68e-07	8.99e-06	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—AKT1—hematologic cancer	3.82e-07	7.34e-06	CbGpPWpGaD
